Webdisclosure.com

PAION AG (FRA:PA8)

24/11/2023 13:46

EQS-Adhoc: PAION AG cancelled guidance for financial year 2023

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

22/11/2023 16:05

EQS-News: PAION AG CHANGES FROM PRIME STANDARD TO GENERAL STANDARD

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

21/11/2023 10:15

EQS-News: PAION AG SIGNS STRATEGIC COOPERATION AGREEMENT WITH YICHANG HUMANWELL

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

31/10/2023 15:16

EQS-News: PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

26/10/2023 12:50

EQS-Adhoc: PAION AG: Filing an application for the opening of insolvency proceedings

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

20/10/2023 07:30

EQS-News: PAION AG to issue approximately 4.8 million shares at EUR 1.90 per share in capital increase with subscription rights

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

19/10/2023 20:56

EQS-Adhoc: PAION AG to issue approximately 4.8 million shares in capital increase with subscription rights

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

13/10/2023 13:06

EQS-News: PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

13/10/2023 12:57

EQS-Adhoc: PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

28/09/2023 14:00

EQS-News: PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE MUNDIPHARMA IN JAPAN

Voir tous les communiqués de PAION AG

1
2
3
4
5
6
7
8
9
10